The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Open accessAbstract
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease burden using currently available data. METHODS: A model was used to estimate NAFLD and NASH disease progression in eight countries based on data for adult prevalence of obesity and type 2 diabetes mellitus (DM). Published estimates and expert consensus were used to build and validate the model projections. RESULTS: If obesity and DM level off in the future, we project a modest growth in total NAFLD cases (0-30%), between 2016-2030, with the highest growth in China as a result of urbanization and the lowest growth in Japan as a result of a shrinking population. However, at the same time, NASH prevalence will increase 15-56%, while liver mortality and advanced liver disease will more than double as a result of an aging/increasing population. CONCLUSIONS: NAFLD and NASH represent a large and growing public health problem and efforts to understand this epidemic and to mitigate the disease burden are needed. If obesity and DM continue to increase at current and historical rates, both NAFLD and NASH prevalence are expected to increase. Since both are reversible, public health campaigns to increase awareness and diagnosis, and to promote diet and exercise can help manage the growth in future disease burden. LAY SUMMARY: Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis can lead to advanced liver disease. Both conditions are becoming increasingly prevalent as the epidemics of obesity and diabetes continue to increase. A mathematical model was built to understand how the disease burden associated with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis will change over time. Results suggest increasing cases of advanced liver disease and liver-related mortality in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Self-citationVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationNonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Self-citationHu, F. B. (2011) · Diabetes Care · doi:10.2337/dc11-0442 · Cited by 1,954
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Self-citationSingh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
Self-citationApplication of a Technique for Research and Development Program Evaluation
Malcolm, D. G., Roseboom, J. H., Clark, C. E., & Fazar, W. (1959) · Operations Research · doi:10.1287/opre.7.5.646 · Cited by 930
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Lazo, M., Hernaez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I., Guallar, E., Koteish, A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 797
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Fracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 711
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 683
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., Subbarayan, S., Webb, A., Hecht, J., & Cusi, K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1966 · Cited by 503
Angulo, P., Bugianesi, E., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Barrera, F., Haflidadottir, S., Day, C. P., & George, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.057 · Cited by 502
Epidemiology of non-alcoholic fatty liver disease in China
Fan, J.-G., & Farrell, G. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.010 · Cited by 502
Type 2 Diabetes in the Young: The Evolving Epidemic
Alberti, G., Zimmet, P., Shaw, J., Bloomgarden, Z., Kaufman, F., Silink, M., & for the Consensus Workshop Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1798 · Cited by 493
Loomba, R., Wolfson, T., Ang, B., Hooker, J., Behling, C., Peterson, M., Valasek, M., Lin, G., Brenner, D., Gamst, A., et al. (2014) · Hepatology · doi:10.1002/hep.27362 · Cited by 489
Self-citationSanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2015) · Hepatology · doi:10.1002/hep.27678 · Cited by 354
Self-citationHuxley, R., James, W. P. T., Barzi, F., Patel, J. V., Lear, S. A., Suriyawongpaisal, P., Janus, E., Caterson, I., Zimmet, P., Prabhakaran, D., et al. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00439.x · Cited by 330
Population-based risk factors and resource utilization for HCC: US perspective
Sanyal, A., Poklepovic, A., Moyneur, E., & Barghout, V. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.506375 · Cited by 312
Self-citationStepanova, M., Rafiq, N., Makhlouf, H., Agrawal, R., Kaur, I., Younoszai, Z., McCullough, A., Goodman, Z., & Younossi, Z. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2743-5 · Cited by 301
Oddy, W. H., Herbison, C. E., Jacoby, P., Ambrosini, G. L., O'Sullivan, T. A., Ayonrinde, O. T., Olynyk, J. K., Black, L. J., Beilin, L. J., Mori, T. A., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.95 · Cited by 256
Fatty liver index and mortality: The cremona study in the 15th year of follow-up
Calori, G., Lattuada, G., Ragogna, F., Garancini, M. P., Crosignani, P., Villa, M., Bosi, E., Ruotolo, G., Piemonti, L., & Perseghin, G. (2011) · Hepatology · doi:10.1002/hep.24356 · Cited by 253
Caballería, L., Pera, G., Auladell, M. A., Torán, P., Muñoz, L., Miranda, D., Alumà, A., Casas, J. D., Sánchez, C., Gil, D., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832fcdf0 · Cited by 239
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Schmidt, C., Flessa, S., & Alte, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.024 · Cited by 208
Juluri, R., Vuppalanchi, R., Olson, J. D., Ünalp, A., Natta, M. L. V., Cummings, O. W., Tonascia, J. A., & Chalasani, N. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dd1348 · Cited by 166
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
Kanwal, F., Kramer, J. R., Duan, Z., Yu, X., White, D., & El-Serag, H. B. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.010 · Cited by 159
The current economic burden of cirrhosis.
Neff, G. W., Duncan, C. W., & Schiff, E. R. (2011) · Europe PMC (PubMed Central) · Cited by 149
Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
Ayonrinde, O. T., Olynyk, J. K., Marsh, J., Beilin, L. J., Mori, T. A., Oddy, W. H., & Adams, L. A. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12666 · Cited by 135
Ayonrinde, O. T., Oddy, W. H., Adams, L. A., Mori, T. A., Beilin, L. J., de Klerk, N. H., & Olynyk, J. K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.029 · Cited by 132
Whalley, S. A., Puvanachandra, P., Desai, A. M., & Kennedy, H. J. (2007) · Clinical Medicine · doi:10.7861/clinmedicine.7-2-119 · Cited by 124
Weinmann, A., Koch, S., Niederle, I. M., Schulze‐Bergkamen, H., König, J., Hoppe‐Lotichius, M., Hansen, T., Pitton, M. B., Düber, C., Otto, G., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a8a793 · Cited by 104
Liver transplantation in Germany
Tacke, F., Kroy, D. C., Barreiros, A. P., & Neumann, U. P. (2016) · Liver Transplantation · doi:10.1002/lt.24461 · Cited by 102
Self-citationEconomic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease
Younossi, Z. M., & Henry, L. L. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0316-5 · Cited by 96
Ground, K. E. (1982) · PubMed · Cited by 70
Younossi, Z. M., Zheng, L., Stepanova, M., Henry, L. L., Venkatesan, C., & Mishra, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000071 · Cited by 49
Clinical Characteristics and Time Trends in Etiology of Hepatocellular Cancer in Germany
Schütte, K., Kipper, M., Kahl, S., Bornschein, J., Götze, T., Adolf, D., Arend, J., Seidensticker, R., Lippert, H., Ricke, J., et al. (2013) · Digestion · doi:10.1159/000346743 · Cited by 41
Kim, Y. S., Jung, E. S., Hur, W., Bae, S. H., Choi, J. Y., Song, M. J., Kim, C. W., Jo, S. H., Lee, C. D., Lee, Y. S., et al. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.2.120 · Cited by 38
Nonalcoholic fatty liver disease
Grant, L. M., & Lisker‐Melman, M. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32100-3 · Cited by 34
Rinella, M. E. (2011) · Hepatology · doi:10.1002/hep.24634 · Cited by 21
Research works printed but not linked: 6
- Kern B, Newsome P, Karam V, Adam R, Berlakovich G, Fritz J, et al. Nonalcoholic steatohepatitis as indication for liver transplantation in Europe. Do we choose the right organs for the right recipients? American Transplant Conference; 2015 May 4, 2015; Philadelphia, Pennsylvania; 2015.
- Marmur, 2010, Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome, Scand J Gastroenterol, 45, 60, 10.3109/00365520903384742 · doi:10.3109/00365520903384742
- Huang, 2013, The national program for deceased organ donation in China, Transplantation, 96, 5, 10.1097/TP.0b013e3182985491 · doi:10.1097/tp.0b013e3182985491
- Delmonico, 2013, A welcomed new national policy in China, Transplantation, 96, 3, 10.1097/TP.0b013e31829949fb · doi:10.1097/tp.0b013e31829949fb
- Wang, 2013, Responses to comments on “Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report”, Hepatobiliary Surg Nutr, 2, 309
- Aberg, 2011, Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score, Liver Transpl, 17, 1333, 10.1002/lt.22388 · doi:10.1002/lt.22388
Cited by
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Self-citation
Metadata
- Authors
- Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., Eguchi, Y., Geier, A., Kondili, L. A., Kroy, D. C., Lazarus, J. V., Loomba, R., Manns, M. P., Marchesini, G., Nakajima, A., Negro, F., Petta, S., Ratziu, V., Romero-Gomez, M., Sanyal, A., Schattenberg, J. M., Tacke, F., Tanaka, J., Trautwein, C., Wei, L., Zeuzem, S., & Razavi, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 69
- Issue
- 4
- Pages
- 896-904
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2806839461
- Cited by
- 1,980
- References
- 60
- FWCI
- 94.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.